DESCRIPTION:
Jack H. Mydlo, MD, and a panel of leading clinicians and researchers review every aspect of the latest surgical, medical, and immunological techniques that can be used in the diagnosis and treatment of renal cancer. These broadly experienced investigators also present a practical account of their best basic research methods, including the use of reverse transcriptase PCR combined with genomic hybridization, cadherin, and metalloproteinase expression to reveal important factors in the detection, staging, aggressiveness, and treatment of this disease. Gene therapy, the generation of monoclonal antibodies, and the use of interferon alpha, GM-CSF, and IL-6 are also discussed. Comprehensive and pioneering, Renal Cancer: Methods and Protocols offers urologists, medical oncologists, laboratory investigators, and pathologists a practical collection of the major cutting-edge techniques and therapies for renal cancer today, together with a view of the highly promising future of gene therapy.
CONTENTS:
PART I INTRODUCTION
1 Renal Cell Carcinoma: Clinical Features and Management
2 Pathology of Kidney Tumors
PART II IN VITRO EXPERIMENTAL TECHNIQUES
3 Telomerase Assay in Renal Cancer
4 Comparative Genomic Hybridization
5 Analyzing the FHIT Gene by RT-PCR, Western Blotting, and Immunohistochemistry
6 Detection of Apoptosis in Renal Cell Carcinoma
7 Fluorescence In Situ Hybridization (FISH) to Metaphase and Interphase Chromosomes
8 Polymerase Chain Reaction Detection of DNA Sequence Deletions
9 Matrix Metalloproteinases and Their Inhibitors
10 Purification of Growth Factor mRNA in Renal Tissues: bFGF-2, FGF-2, TGF.., and EGFR
11 Laser-Capture Microdissection
12 Expression of c-met and WT-1
13 Molecular Analysis of the von Hippel-Lindau Disease Gene
14 Experimental Models and Methods in Antibody Targeting of Renal Cell Carcinoma
PART III IN VIVO EXPERIMENTAL TECHNIQUES
15 Orthotopic Model of Renal Cell Carcinoma
16 Murine Animal Model
17 Angiogenesis Assays
18 Antiangiogenic Approaches to Renal Cell Carcinoma: Assays for Inhibitors and Clinical Trials
PART IV CLINICAL TRIALS AND EXPERIMENTS
19 Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma
20 Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination
21 Monoclonal Antibodies: Generation and Clinical Use
22 Treatment Strategies in Metastatic Renal Cell Carcinoma: Cytokines, Vaccines, and Gene Therapy
23 Assessment of T-Cell Immune Dysfunction in Patients with Renal Cell Carcinoma
24 Transforming Growth Factor-..1 as a Novel Marker of Response to Therapy for Renal Cell Carcinoma
25 Static and Flow Cytometry
